200,000+ products from a single source!
sales@angenechem.com
Home > Sulfanilamide > 2386-58-5
CAS No: 2386-58-5 Catalog No: AG00BDZO MDL No:MFCD00051751
| Title | Journal |
|---|---|
| Synthesis of a unique isoindoline/tetrahydroisoquinoline-based tricyclic sultam library utilizing a Heck-aza-Michael strategy. | ACS combinatorial science 20120312 |
| Automated synthesis of a 184-member library of thiadiazepan-1,1-dioxide-4-ones. | ACS combinatorial science 20110509 |
| In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi. | PLoS neglected tropical diseases 20100901 |
| Designed semisynthetic protein inhibitors of Ub/Ubl E1 activating enzymes. | Journal of the American Chemical Society 20100217 |
| 'Click, click, cyclize': a DOS approach to sultams utilizing vinyl sulfonamide linchpins. | Organic letters 20090205 |
| A versatile synthesis of 2,4-substituted oxazoles. | Chemical communications (Cambridge, England) 20080828 |
| Indium-mediated tandem radical addition-cyclization-trap reactions in aqueous media. | Organic letters 20031016 |
| Evaluation of vinylsulfamides as sulfhydryl selective alkylation reagents in protein modification. | Bioorganic & medicinal chemistry letters 20030210 |
| omega-(Imidazol-4-yl)alkane-1-sulfonamides: a new series of potent histamine H(3) receptor antagonists. | Bioorganic & medicinal chemistry 20020201 |
| Synthesis and structure-activity relationships in a series of ethenesulfonamide derivatives, a novel class of endothelin receptor antagonists. | Chemical & pharmaceutical bulletin 20011201 |
| Ethenesulfonamide and ethanesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists. | Bioorganic & medicinal chemistry 20011101 |
| Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain. | Bioorganic & medicinal chemistry letters 20011022 |
| Ethenesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists. | Chemical & pharmaceutical bulletin 20010501 |
| Tyrosine kinase inhibitors. 18. 6-Substituted 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as soluble, irreversible inhibitors of the epidermal growth factor receptor. | Journal of medicinal chemistry 20010201 |
© 2019 Angene International Limited. All rights Reserved.